![Global Cancer Immunotherapy Market](https://res.cloudinary.com/devmoveo/image/upload/v1706607512/skyquest/report/php3NJPKx.jpg)
Report ID: SQMIG35I2296
Report ID:
SQMIG35I2296 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
120 |
Figures:
69
Cancer Immunotherapy Market Drivers
High Efficacy of Immunotherapy to Boost Market Growth
Cancer Immunotherapy Market Restraints
Huge Investments for R&D to Hamper Market Growth
High manufacturing cost and high price for end-user as well is the major factor anticipated to hamper the growth of the global cancer immunotherapy market over the forecast period. Enhancement and development in treatment requires a very large amount of resources and high investment, which is expected to slow down the growth of the market in the coming years.
Lack of medical access in remote areas and geographical challenges are likely to limit the awareness for cancer immunotherapies.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONCancer Immunotherapy Market size was valued at USD 39.05 billion in 2019 and is poised to grow from USD 85.6 billion in 2023 to USD 309.67 billion by 2031, growing at a CAGR of 9.6% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35I2296